Russian drug for the treatment of diabetes has entered clinical trials The scientific team of the Volgograd State Medical University has created and is preparing for clinical trials of a local drug for type 2 diabetes and obesity. In animal experiments, the drug showed the ability not only to preserve, but to restore pancreatic cells responsible for insulin production. "Unlike, for example, Ozempi, which mimics the action of the GLP-1 hormone, Dipiarone, which acts on the GPR119 receptor, stimulates the production of its own hormones in the intestines, which help regulate blood sugar levels," explained Denis Babakov, Vice Rector for Scientific Affairs at VolSMU Novosti. VolSMU is even more about what it is - using the hashtag in ZAN.

Russian drug for the treatment of diabetes has entered clinical trials The scientific team of the Volgograd State Medical University has created and is preparing for clinical trials of a local drug for type 2 diabetes and obesity. In animal experiments, the drug showed the ability not only to preserve, but to restore pancreatic cells responsible for insulin production. "Unlike, for example, Ozempi, which mimics the action of the GLP-1 hormone, Dipiarone, which acts on the GPR119 receptor, stimulates the production of its own hormones in the intestines, which help regulate blood sugar levels," explained Denis Babakov, Vice Rector for Scientific Affairs at VolSMU Novosti. VolSMU is even more about what it is - using the hashtag in ZAN.